SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-018540
Filing Date
2024-05-29
Accepted
2024-05-29 07:00:50
Documents
21
Period of Report
2024-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20240528_8k.htm   iXBRL 8-K 43163
2 EXHIBIT 4.1 ex_680208.htm EX-4.1 102996
3 EXHIBIT 4.2 ex_680209.htm EX-4.2 9335
4 EXHIBIT 5.1 ex_680210.htm EX-5.1 10534
5 EXHIBIT 10.1 ex_680211.htm EX-10.1 219196
6 EXHIBIT 99.1 ex_680212.htm EX-99.1 15891
11 opinionfooter.jpg GRAPHIC 9431
12 opinionlogo.jpg GRAPHIC 6013
  Complete submission text file 0001437749-24-018540.txt   662787

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rvph-20240528.xsd EX-101.SCH 3914
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20240528_def.xml EX-101.DEF 13477
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20240528_lab.xml EX-101.LAB 17737
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20240528_pre.xml EX-101.PRE 13454
24 EXTRACTED XBRL INSTANCE DOCUMENT rvph20240528_8k_htm.xml XML 4878
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 24993982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)